title: ACR Appropriateness Criteria Renal Cell Carcinoma Staging.
abstract: Renal cell carcinoma accounts for 2%-3% of all visceral malignancies. Preoperative imaging can provide important staging and anatomic information to guide treatment decisions. Size of the primary tumor and degree of local invasion, such as involvement of perinephric fat or renal sinus fat, and tumor thrombus in renal veins and inferior vena cava are important detriments to local staging of primary tumor. Both kidneys are assessed for presence of other synchronous lesions. The ACR Appropriateness Criteria(®) are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and application by the panel of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
authors.affiliation: University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: rvikram@mdanderson.org.
authors.forename: Raghunandan
authors.initials: R
authors.lastname: Vikram
authors.affiliation: Rhode Island Hospital, Providence, Rhode Island.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Beland
authors.affiliation: Albert Einstein College of Medicine, Bronx, New York, Society of Nuclear Medicine and Molecular Imaging.
authors.forename: M Donald
authors.initials: MD
authors.lastname: Blaufox
authors.affiliation: Emory University Hospital, Atlanta, Georgia.
authors.forename: Courtney Coursey
authors.initials: CC
authors.lastname: Moreno
authors.affiliation: University of Washington, Seattle, Washington, American Urological Association.
authors.forename: John L
authors.initials: JL
authors.lastname: Gore
authors.affiliation: Scottsdale Medical Imaging, Scottsdale, Arizona.
authors.forename: Howard J
authors.initials: HJ
authors.lastname: Harvin
authors.affiliation: University of Utah, Salt Lake City, Utah.
authors.forename: Marta E
authors.initials: ME
authors.lastname: Heilbrun
authors.affiliation: The University of Chicago Medical Center, Chicago, Illinois.
authors.forename: Stanley L
authors.initials: SL
authors.lastname: Liauw
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Paul L
authors.initials: PL
authors.lastname: Nguyen
authors.affiliation: Northwestern University, Chicago, Illinois.
authors.forename: Paul
authors.initials: P
authors.lastname: Nikolaidis
authors.affiliation: Duke University Medical Center, Durham, North Carolina, American Urological Association.
authors.forename: Glenn M
authors.initials: GM
authors.lastname: Preminger
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Andrei S
authors.initials: AS
authors.lastname: Purysko
authors.affiliation: University of California Los Angeles Medical Center, Los Angeles, California.
authors.forename: Steven S
authors.initials: SS
authors.lastname: Raman
authors.affiliation: George Washington University Hospital, Washington, District of Columbia.
authors.forename: Myles T
authors.initials: MT
authors.lastname: Taffel
authors.affiliation: University of California San Francisco School of Medicine, San Francisco, California.
authors.forename: Zhen J
authors.initials: ZJ
authors.lastname: Wang
authors.affiliation: Oakland University William Beaumont School of Medicine, Troy, Michigan.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Weinfeld
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Erick M
authors.initials: EM
authors.lastname: Remer
authors.affiliation: University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Lockhart
mesh_terms: D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging* / Q000473:pathology*; D003287:Contrast Media; D003952:Diagnostic Imaging / Q000592:standards*; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*; D009367:Neoplasm Staging; D019275:Radiopharmaceuticals
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals
keywords: Appropriateness Criteria; CT; Imaging; MRI; Staging; renal cell carcinoma